2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Antithrombin III Deficiency: new trials by email Literature Review of Antithrombin III Deficiency trials Research Report on Antithrombin III Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery Recombinant human antithrombin (rhAT) - Antithrombin III Deficiency | Phase 3 | Completed | rEVO Biologics | 18 | 2005-04-01 | 2012-08-17 |
| Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. Recombinant Human Antithrombin (rhAT) - Antithrombin Deficiency, Congenital | Phase 3 | Completed | rEVO Biologics | 14 | 2002-12-01 | 2012-10-16 |
Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Blood Protein Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Thrombophilia (2)
rEVO Biologics (2)
France (2) · Germany (2) · Italy (2) · United Kingdom (2) · United States (2) · Australia (1) · Austria (1) · Canada (1) · Sweden (1)
Cambell Tait, MD (1) · Robert C Tait, MD (1)